Screening of hybridoma cell lines secreting monoclonal antibodies specific for staphylococcal enterotoxin B (SEB) derived from Staphylococcus aureus
Author affiliations
DOI:
https://doi.org/10.15625/1811-4989/14/1/9288Keywords:
ELISA, hybridoma line, monoclonal antibody, SEB recombinant antigen, Western blotAbstract
Staphylococcus aureus (S. aureus) produces 11 types of toxins and more than 20 different Staphylococcal enterotoxins (SEs), including SEA to SEE, SEG to SER and SEU. Among them, enterotoxin type B (Staphylococcal enterotoxin B - SEB) is quite heat stable and causes gastrointestinal diseases in food poisoning. The symptoms of SEB intoxication begin with the onset of sudden fever, about 40oC to 41oC, chills, headache, muscle aches and dry cough. Some patients feel shortness of breath and chest pain. Although SEB is not considered lethal, high level of exposure can lead to shock and death. Therefore, a nontoxic SEB recombinant antigen was produced to immunize mice to create B lymphocytes. Myeloma cells were fused with the B lymphocytes to generate hybridoma lines. The screening of monoclonal antibodies for the SEB antigen was determined by ELISA and Western blot tests. This study demonstrates that an SEB recombinant antigen can immunize a response against SEB in BALB/c mice. The production of monoclonal antibodies will be used to make a rapid detection strip for SEB based on immunochromatography.Downloads
Downloads
Published
How to Cite
Issue
Section
License
Vietnam Journal of Biotechnology is a peer-reviewed, open access journal dedicated to the dissemination of scientific knowledge and research findings in the field of biotechnology. All published articles are freely accessible and downloadable by readers worldwide without any subscription or access fees.
All articles published in Vietnam Journal of Biotechnology are distributed under the terms of the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) License. This license allows users to share, copy, redistribute, adapt, and reproduce the material in any medium or format, provided that appropriate credit is given to the original author(s) and source, and that any derivative works are distributed under the same license terms.
The copyright of each published article remains with the respective author(s) without restriction. By submitting and granting permission for publication through the journal’s submission system or other communication channels, authors authorize Vietnam Journal of Biotechnology to publish and identify itself as the original publisher of the work. Authors also acknowledge and agree to comply with the terms and conditions of the CC BY-SA 4.0 License and the policies established by the journal.
